Björn Eriksson is Director General of the Swedish Medical Products Agency since March 2021. Björn Eriksson is a cardiologist and has worked with clinical work, drug development and administrative management in healthcare.
Björn Eriksson, Director General of the Swedish Medical Products Agency, is a new Member of the University Board from 13 June 2022. Photo: Jeanette Hägglund.
2022-06-17 New Member of the University Board
Björn Eriksson, generaldirektör för Läkemedelsverket, is a new Member of the University Board from 13 June 2022. He is replacing Johan Söderström.
Read more
MPA’s Björn Eriksson wants to strengthen the collaboration with the Faculty of Pharmacy (news item 4 May 2022)